相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of postsurgery circulating tumorDNAin nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Jeanne Tie et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial
Julien Taieb et al.
CLINICAL CANCER RESEARCH (2021)
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Huiyan Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Association of Observed Perioperative Cell-Free DNA Dynamics With Early Recurrence in Patients With Colon Cancer
Christina A. Fleming et al.
JAMA SURGERY (2020)
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020
Jim F. Huggett et al.
CLINICAL CHEMISTRY (2020)
Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response
Filip Pazdirek et al.
FRONTIERS IN ONCOLOGY (2020)
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie et al.
GUT (2019)
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer
Raja R. Narayan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
Francois-Clement Bidard et al.
CELLS (2019)
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie et al.
JAMA ONCOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
J. B. Bachet et al.
ANNALS OF ONCOLOGY (2018)
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients
Nele Boeckx et al.
CLINICAL COLORECTAL CANCER (2018)
Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival
David H. Murray et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
Erin L. Symonds et al.
CLINICAL EPIGENETICS (2018)
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Fanny Garlan et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Scholer et al.
CLINICAL CANCER RESEARCH (2017)
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
J. Vidal et al.
ANNALS OF ONCOLOGY (2017)
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Thomas Reinert et al.
GUT (2016)
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
Sonia Garrigou et al.
CLINICAL CHEMISTRY (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J. Tie et al.
ANNALS OF ONCOLOGY (2015)
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
Karen Lise Garm Spindler et al.
PLOS ONE (2015)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale et al.
NATURE (2012)
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Diaz et al.
NATURE (2012)
Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Theo deVos et al.
CLINICAL CHEMISTRY (2009)
分享论文
